Neurontin and Drooling - a phase IV clinical study of FDA data

Summary:

Drooling is reported as a side effect among people who take Neurontin (gabapentin), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Seroquel, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Drooling when taking Neurontin. It is created by eHealthMe based on reports of 103,969 people who have side effects when taking Neurontin from the FDA, and is updated regularly.

What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.

What is Drooling?

Drooling (drop saliva uncontrollably from the mouth) is found to be associated with 497 drugs and 941 conditions by eHealthMe. Check the latest studies of Drooling.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

103,969 people reported to have side effects when taking Neurontin.
Among them, 92 people (0.09%) have Drooling.

Among these 92 people:

How long have people been on Neurontin when they have Drooling? *

What is the gender of people who have Drooling when taking Neurontin? *

female: 74.44 %
male: 25.56 %

What is the age of people who have Drooling when taking Neurontin? *

What are other drugs people take besides Neurontin? *

What are other side effects people have besides Drooling? *

Speech Impairment (Adult) (inability to speak (adult)): 33 people, 35.87%
Weakness: 21 people, 22.83%
Drug Ineffective: 19 people, 20.65%
Stress And Anxiety: 19 people, 20.65%
Fall: 17 people, 18.48%
Memory Loss: 16 people, 17.39%
Hypoaesthesia (reduced sense of touch or sensation): 14 people, 15.22%
Headache (pain in head): 12 people, 13.04%
Balance Disorder: 12 people, 13.04%
Dyskinesia (abnormality or impairment of voluntary movement): 11 people, 11.96%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 12 people, 13.04%
Depression: 7 people, 7.61%
Ill-Defined Disorder: 7 people, 7.61%
Stress And Anxiety: 6 people, 6.52%
Insomnia (sleeplessness): 6 people, 6.52%
Sleep Disorder: 5 people, 5.43%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 5.43%
Suicidal Ideation: 4 people, 4.35%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 4.35%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Neurontin and have Drooling?

- Check whether Drooling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neurontin:

Neurontin (107,468 reports)

Drooling treatments and more:

Drooling (8,115 reports)

Browse all side effects of Neurontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drooling:

Drooling (497 drugs)

Browse all the conditions that are associated with Drooling:

Drooling (941 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Neurontin) and Neurontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.